Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ)
CNY 5.02
(1.62%)
CNY 5.02
(1.62%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -367.05 Million CNY | 25.15% |
| 2022 | -490.36 Million CNY | 60.32% |
| 2021 | -1.23 Billion CNY | 19.72% |
| 2020 | -1.53 Billion CNY | -13.49% |
| 2019 | -1.35 Billion CNY | -3.3% |
| 2018 | -1.31 Billion CNY | 19.69% |
| 2017 | -1.63 Billion CNY | 12.45% |
| 2016 | -1.86 Billion CNY | -1519.33% |
| 2015 | -115.32 Million CNY | -1004.03% |
| 2014 | 12.75 Million CNY | -98.42% |
| 2013 | 806.01 Million CNY | 50.26% |
| 2012 | 536.39 Million CNY | 108.42% |
| 2011 | 257.36 Million CNY | 142.75% |
| 2010 | 106.01 Million CNY | -9.3% |
| 2009 | 116.88 Million CNY | -5.85% |
| 2008 | 124.14 Million CNY | 150.87% |
| 2007 | 49.48 Million CNY | 197.31% |
| 2006 | -50.85 Million CNY | -130.02% |
| 2005 | 169.38 Million CNY | 28.89% |
| 2004 | 131.42 Million CNY | 1.85% |
| 2003 | 129.03 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -256.69 Million CNY | 30.07% |
| 2024 Q2 | -249.83 Million CNY | 2.67% |
| 2024 Q3 | -381.73 Million CNY | -49.65% |
| 2023 Q1 | -755.54 Million CNY | -54.08% |
| 2023 FY | -367.05 Million CNY | 25.15% |
| 2023 Q4 | -367.05 Million CNY | 34.88% |
| 2023 Q3 | -563.65 Million CNY | -7.03% |
| 2023 Q2 | -526.6 Million CNY | 30.3% |
| 2022 Q4 | -490.36 Million CNY | 4.51% |
| 2022 FY | -490.36 Million CNY | 60.32% |
| 2022 Q1 | -1.11 Billion CNY | 9.96% |
| 2022 Q2 | -501.07 Million CNY | 54.97% |
| 2022 Q3 | -513.5 Million CNY | -2.48% |
| 2021 Q3 | -1.35 Billion CNY | 3.61% |
| 2021 Q4 | -1.23 Billion CNY | 8.96% |
| 2021 FY | -1.23 Billion CNY | 19.72% |
| 2021 Q1 | -1.52 Billion CNY | 0.99% |
| 2021 Q2 | -1.4 Billion CNY | 7.61% |
| 2020 Q3 | -1.32 Billion CNY | -12.42% |
| 2020 FY | -1.53 Billion CNY | -13.49% |
| 2020 Q4 | -1.53 Billion CNY | -16.09% |
| 2020 Q1 | -1.04 Billion CNY | 23.07% |
| 2020 Q2 | -1.17 Billion CNY | -13.04% |
| 2019 Q2 | -1.17 Billion CNY | 19.03% |
| 2019 FY | -1.35 Billion CNY | -3.3% |
| 2019 Q4 | -1.35 Billion CNY | -8.51% |
| 2019 Q3 | -1.24 Billion CNY | -6.6% |
| 2019 Q1 | -1.44 Billion CNY | -10.29% |
| 2018 FY | -1.31 Billion CNY | 19.69% |
| 2018 Q1 | -1.57 Billion CNY | 3.51% |
| 2018 Q4 | -1.31 Billion CNY | -50.61% |
| 2018 Q3 | -871.77 Million CNY | 27.31% |
| 2018 Q2 | -1.19 Billion CNY | 23.98% |
| 2017 Q1 | -2 Billion CNY | -7.32% |
| 2017 Q4 | -1.63 Billion CNY | -57.82% |
| 2017 Q3 | -1.03 Billion CNY | 27.28% |
| 2017 Q2 | -1.42 Billion CNY | 28.92% |
| 2017 FY | -1.63 Billion CNY | 12.45% |
| 2016 Q3 | -1.17 Billion CNY | -2496.36% |
| 2016 Q4 | -1.86 Billion CNY | -59.6% |
| 2016 Q1 | 27.53 Million CNY | 123.88% |
| 2016 FY | -1.86 Billion CNY | -1519.33% |
| 2016 Q2 | -45.06 Million CNY | -263.66% |
| 2015 FY | -115.32 Million CNY | -1004.03% |
| 2015 Q1 | -69.45 Million CNY | -644.45% |
| 2015 Q2 | 112.43 Million CNY | 261.88% |
| 2015 Q3 | 39.76 Million CNY | -64.63% |
| 2015 Q4 | -115.32 Million CNY | -390.03% |
| 2014 Q1 | 807.17 Million CNY | 0.14% |
| 2014 Q2 | 772.02 Million CNY | -4.36% |
| 2014 Q3 | 766.24 Million CNY | -0.75% |
| 2014 Q4 | 12.75 Million CNY | -98.34% |
| 2014 FY | 12.75 Million CNY | -98.42% |
| 2013 FY | 806.01 Million CNY | 50.26% |
| 2013 Q4 | 806.01 Million CNY | 7.31% |
| 2013 Q3 | 751.1 Million CNY | 6.19% |
| 2013 Q2 | 707.34 Million CNY | 7.95% |
| 2013 Q1 | 655.26 Million CNY | 22.16% |
| 2012 Q2 | 384.66 Million CNY | 43.06% |
| 2012 Q1 | 268.88 Million CNY | 4.48% |
| 2012 FY | 536.39 Million CNY | 108.42% |
| 2012 Q4 | 536.39 Million CNY | 18.06% |
| 2012 Q3 | 454.33 Million CNY | 18.11% |
| 2011 Q1 | 134.5 Million CNY | 26.87% |
| 2011 FY | 257.36 Million CNY | 142.75% |
| 2011 Q4 | 257.36 Million CNY | 26.08% |
| 2011 Q3 | 204.12 Million CNY | 40.11% |
| 2011 Q2 | 145.68 Million CNY | 8.31% |
| 2010 Q2 | 119.69 Million CNY | 65.48% |
| 2010 Q3 | 62.15 Million CNY | -48.07% |
| 2010 FY | 106.01 Million CNY | -9.3% |
| 2010 Q4 | 106.01 Million CNY | 70.56% |
| 2010 Q1 | 72.33 Million CNY | -38.12% |
| 2009 Q3 | 124.32 Million CNY | 42.44% |
| 2009 Q2 | 87.28 Million CNY | 107.18% |
| 2009 FY | 116.88 Million CNY | -5.85% |
| 2009 Q1 | 42.12 Million CNY | -66.07% |
| 2009 Q4 | 116.88 Million CNY | -5.98% |
| 2008 Q2 | 115.25 Million CNY | 12.98% |
| 2008 Q3 | 108.55 Million CNY | -5.81% |
| 2008 Q4 | 124.14 Million CNY | 14.36% |
| 2008 FY | 124.14 Million CNY | 150.87% |
| 2008 Q1 | 102.01 Million CNY | 106.15% |
| 2007 Q3 | 25.13 Million CNY | -17.51% |
| 2007 Q2 | 30.47 Million CNY | 498.46% |
| 2007 Q4 | 49.48 Million CNY | 96.87% |
| 2007 Q1 | -7.64 Million CNY | 84.96% |
| 2007 FY | 49.48 Million CNY | 197.31% |
| 2006 FY | -50.85 Million CNY | -130.02% |
| 2006 Q4 | -50.85 Million CNY | -123.85% |
| 2006 Q2 | 179.32 Million CNY | 0.0% |
| 2006 Q3 | 213.19 Million CNY | 18.89% |
| 2005 Q4 | 169.38 Million CNY | 0.0% |
| 2005 FY | 169.38 Million CNY | 28.89% |
| 2004 FY | 131.42 Million CNY | 1.85% |
| 2003 FY | 129.03 Million CNY | 0.0% |